CDC Recommendations Fuel Production of Viral Transport Medium for COVID-19 Research

The demand for swab and viral transport medium has increased during the COVID-19 (coronavirus) pandemic. Since research institutes and labs have intensified their experiments for developing COVID-19 vaccines, companies in the swab and viral transport medium market have increased their production capacities to develop products useful for viral collection, maintenance, and culture. For instance, Innovative Research - a manufacturer of high quality and affordable research materials, developing viral transport medium to support global research in COVID-19.

Rapid antigen testing and molecular assay experiments have fueled the demand for swab and viral transport medium during the ongoing coronavirus crisis. Long-term freezers and direct fluorescent antibody (DVA) applications are creating incremental opportunities for companies in the swab and viral transport medium market. They are following CDC (Centers for Disease Control and Prevention) recommendations to develop the formulations of products.

Request a sample to get extensive insights into the Swab and Viral Transport Medium Market

Sterile Swabs Facilitate Minimal Contact of Healthcare Workers with COVID-19 Samples 

Overwhelming repercussions of the COVID-19 outbreak are being experienced in various sectors. In order to stabilize business activities like before, there is an unprecedented demand for COVID-19 vaccines to revive economic growth worldwide. Hence, technologists at the Sree Chitra Triunal Institute for Medical Sciences and Technology (SCTIMST) and Mallelil Industries co-developed oral and nasal swabs for COVID-19 testing. Companies in the swab and viral transport medium market are increasing the availability of sterile and ready-to-use swabs for COVID-19 testing.

Since COVID-19 cases continue to rise in India, companies in the India swab and viral transport medium market are manufacturing polymeric foam-tipped swabs with flexible plastic handles to deliver efficient recovery of viral RNA. Improved specimen collection with minimum discomfort to patients is the key to develop oral and nasal swabs. However, minimal contact of healthcare workers with samples during packing is another important aspect of COVID-19 testing.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Appropriate Specimen Collection Crucial for Influenza Diagnosis

Companies in the swab and viral transport medium market are innovating in kits containing vials, double-ended flocked swabs, antibiotics, and other items that inhibit bacterial or fungal contamination. They are focusing on improved formulation of Hanks solution to contain the reproduction of bacterial and fungal flora. Innovative viral transport medium products are bolstering growth of the swab and viral transport medium market, which is estimated to reach a value of US$ 2.2 Bn by 2030.

With the onset of the flu season, manufacturers are developing viral transport medium for influenza diagnostics. Influenza-related morbidity and mortality is a major concern in healthcare in western countries. Hence, manufacturers are increasing their R&D capabilities to manufacture swabs and viral transport medium that facilitates appropriate specimen collection for improved patient care.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Swab and Viral Transport Medium Market

False Negatives and Reinfections Hamper Diagnosis of COVID-19 in Patients

The swab and viral transport medium market is projected to advance at a sluggish CAGR of ~3% during the forecast period. This is evident since the issue of false negatives and reinfection is surfacing in COVID-19 diagnosis. As such, healthcare professionals are facing issues to test performance and interpretation of COVID-19 testing, as the level of viral RNA in many cases is below the limit of detection. Hence, manufacturers in the swab and viral transport medium market are following CDC guidelines to develop products that facilitate appropriate specimen collection.

A good specimen collection leads to accurate results, thus improving clinical outcomes for COVID-19 testing. As such, nasopharyngeal (NP) swabs are being highly publicized for COVID-19 testing and is recommended by the CDC. On the other hand, manufacturers are developing nasal turbinate swabs and self-collected swabs for efficient collection of the coronavirus using saliva to diagnose the infection.

Strategic Agreements Strengthen Distribution of Swab and Viral Transport Medium

Companies in the swab and viral transport medium market are increasing efforts to develop FDA (Food & Drug Association)-approved products to gain global recognition. For instance, Hardy Diagnostics— an FDA-licensed manufacturer of medical devices for microbiological testing has introduced the Universal Transport Medium (UTM)® which is suitable for collection, maintenance, and long-term freeze storage of clinical specimens. Prolonged viability of organisms is highly preferred by researchers in swab and viral transport medium.

Manufacturers in the swab and viral transport medium market are innovating in products that facilitate rapid antigen testing, viral culture, and molecular-based assay. They are adopting the vertically integrated approach to manufacture swab and viral transport medium in order to gain complete control over the entire process. Companies are entering into strategic agreements to strengthen the distribution of products.

3D Printed Swab Gains Popularity for Cost-efficient Production Using Renewable Resources

The 3 dimensional (3D) printers are being used to produce cost-efficient nasopharyngeal swabs. Companies in the swab and viral transport medium market are using fused deposition modelling (FDM) printers to manufacture nasopharyngeal swab in a cost-efficient manner. Apart from hospital and retail pharmacies, manufacturers are now realizing the potential of online pharmacies. Hence, they are collaborating with e-Commerce giants to broaden their revenue streams.

Manufacturers are using FDA-approved biocompatible materials in swab such as polylactic acid (PLA) plastic filament. They are making use of renewable resources such as sugarcane and tapioca roots to produce 3D printed swab. On the other hand, companies are using flocking methods to electrostatically deposit small fibers of synthetic materials onto an adhesive-coated surface to produce nasopharyngeal swabs. In order to eliminate the need for adhesives, manufacturers are using mini blunt-ended hooks to secure polyester threads of nasopharyngeal swabs.

Analysts’ Viewpoint

The FDA has relaxed its regulations for the production of swab and viral transport medium used in COVID-19 diagnosis. However, there is a need for pandemic preparedness funding to develop technologies that are agile and quickly adapt to the introduction of new pathogens in the environment in the upcoming years. Hence, companies in the swab and viral transport medium market should invest in state-of-the-art facilities that prevent the shortage of products in future pandemic-like situations and cater to rapid testing applications. Manufacturers are increasing their portfolio in products that facilitate appropriate collection of chlamydia, ureaplasma, and mycoplasma that remain stable even at room temperature.

Swab and Viral Transport Medium Market: Overview

  • According to Transparency Market Research’s latest research report on the global swab and viral transport medium market for the historical period 2018-2019 and the forecast period 2020-2030, increase in demand for swabs and viral transport medium, owing to COVID-19 pandemic is projected to drive the global swab and viral transport medium market in the near future
  • According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is anticipated to expand at a CAGR of ~3% from 2020 to 2030

Increase in Demand for Swabs and Viral Transport Medium Owing to COVID-19 Pandemic : Key Driver of Swab and Viral Transport Medium Market

  • According to the Centers for Disease Control and Prevention, as of January 21, 2020, the total cases of COVID-19 in the U.S. stood at 5,340,232 and total deaths at 168,696. Cases among healthcare personnel were 135,298 and 629 deaths.
  • The COVID-19 pandemic has led to an unprecedented need of diagnostic reverse transcription-PCR (RT-PCR) testing
  • The ideal way for taking the specimen type is a nasopharyngeal (NP) swab, which can be easily transported to a molecular microbiology laboratory in viral transport medium (VTM) and the swabs for the further examinations
  • There are several low cost techniques such as saline, with RT-PCR and NAAT assays for respiratory pathogens and its analysis. These have been developed and the FDA has cleared for use with more complex transport media such as VTM and universal transport medium [UTM].
  • Hence, increase in demand for swabs and viral transport medium, owing to COVID-19 pandemic is expected to drive the global swab and viral transport market

Surge in Government Initiatives for Infectious and Non-infectious Diseases: Major Driver of Swab and Viral Transport Medium Market

  • Addressing the needs of patients with infectious and non-infectious diseases has become a priority for healthcare providers and government organizations across the globe
  • Moreover, the U.S. Administration for Community Living, Department of Health and Human Services, offers sponsorship for various studies on sepsis. These government initiatives encourage the development of new therapies for the treatment of infectious diseases.

Increase in Geriatric Population: Major Driver of Swab and Viral Transport Medium Market

  • According to the United Nations Department of Economic and Social Affairs, Population Division, globally, there were 703 million persons aged 65 or over in 2019
  • Eastern and Southeastern Asia were home to a significantly large number of the world’s geriatric population of ~260 million, which is followed by Europe and Northern America over 200 million
  • The global geriatric population over the next three decades is projected to more than double, reaching over 1.5 billion persons in 2050
  • The largest increase, about 312 million individuals, is projected to occur in Eastern and Southeastern Asia growing from 261 million in 2019 to 573 million persons aged 65 years or over, in 2050
  • According to data from World Population Prospects: the 2019 Revision, by 2050, one in six people in the world would be over age 65 (16%), up from one in 11 in 2019 (9%)
  • According to the World Health Organization (WHO), 38 million children under the age of 5 were overweight or obese in 2019. In 2016, more than 1.9 billion adults aged 18 years and older were overweight. Of these, over 650 million adults were obese.
  • Once considered a high-income country issue, overweight and obesity are presently on the rise in low- and middle-income countries, particularly in urban settings
  • Thus, rise in geriatric and obese population drives diseases and swab and viral transport medium market

Swab and Viral Transport Medium Market: Competition Landscape

  • This report profiles major players operating in the global swab and viral transport medium market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global swab and viral transport medium market is moderately fragmented with the presence of a large number of leading players in the international market and several small players in regional markets. Top players hold a major share of the global swab and viral transport medium market.
  • Prominent players operating in the global swab and viral transport medium market include -
    • Thermo Fisher Scientific
    • Becton
    • Dickinson and Company
    • MWE
    • Titan Biotech Ltd
    • COPAN Diagnostics Inc.
    • MANTACC
    • Puritan Medical Products
    • YOCON Biology
    • Trinity Biotech
    • VIRCELL S.L.
  • The report on the global swab & viral transport medium market discusses individual strategies, followed by company profiles of manufacturers of vaccines. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global swab and viral transport medium market.

Swab and Viral Transport Medium Market - Segmentation

Type

  • Swab Type
    • Nasal Swabs
    • Nasopharyngeal Swabs
    • Throat Swabs
  • Transport Medium

Application

  • Viral Infection Diagnosis
    • COVID-19
    • Influenza
    • Herpes Simplex Virus
    • Varicella-zoster Virus
    • Others
  • Others

End User

  • Hospitals & Clinics
  • Microbiology Laboratories
  • Diagnostic Laboratories
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

Swabs and viral transport medium market to reach valuation of US$ 2.2 Bn by 2030

Swabs and viral transport medium market is anticipated to expand at a CAGR of ~3% from 2020 to 2030

Swabs and viral transport medium market is driven by increase in demand for swabs and viral transport medium, owing to COVID-19 pandemic

North America accounted for a significant share of the global swab and viral transport medium market

Key players in the global swab and viral transport medium market include Thermo Fisher Scientific, Becton, Dickinson and Company, MWE, Titan Biotech Ltd

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Swab and Viral Transport Medium Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Swab and Viral Transport Medium Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Regulatory Scenario by Region/Globally

    5.2. Key Mergers & Acquisitions 

6. Global Swab and Viral Transport Medium Market Analysis and Forecast, by Product 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030

        6.3.1. Swab Type

            6.3.1.1. Nasal Swabs

            6.3.1.2. Nasopharyngeal Swabs

            6.3.1.3. Throat Swabs

        6.3.2. Transport Medium 

    6.4. Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Product 

7. Global Swab and Viral Transport Medium Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030

        7.3.1. Viral Infection Diagnosis

            7.3.1.1. COVID-19

            7.3.1.2. Influenza

            7.3.1.3. Herpes Simplex Virus

            7.3.1.4. Varicella-zoster Virus

            7.3.1.5. Others

        7.3.2. Others 

    7.4. Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Application

8. Global Swab and Viral Transport Medium Market Analysis and Forecast, by End-user 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030

        8.3.1. Hospitals & Clinics

        8.3.2. Microbiology Laboratories

        8.3.3. Diagnostic Laboratories

        8.3.4. Others  

    8.4. Global Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user 

9. Global Swab and Viral Transport Medium Market Analysis and Forecast, by Region

    9.1. 10.1. Key Findings

    9.2. 10.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Region

10. North America Swab and Viral Transport Medium Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030

        10.2.1. Swab Type

            10.2.1.1. Nasal Swabs

            10.2.1.2. Nasopharyngeal Swabs

            10.2.1.3. Throat Swabs

        10.2.2. Transport Medium 

    10.3. North America Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030

        10.3.1. Viral Infection Diagnosis

            10.3.1.1. COVID-19

            10.3.1.2. Influenza

            10.3.1.3. Herpes Simplex Virus

            10.3.1.4. Varicella-zoster Virus

            10.3.1.5. Others

        10.3.2. Others 

    10.4. North America Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030

        10.4.1. Hospitals & Clinics

        10.4.2. Microbiology Laboratories

        10.4.3. Diagnostic Laboratories

        10.4.4. Others  

    10.5. North America Swab and Viral Transport Medium Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Swab and Viral Transport Medium Market Attractiveness Analysis 

        10.6.1. By Product 

        10.6.2. By Application 

        10.6.3. By End-user 

        10.6.4. By Country

11. Europe Swab and Viral Transport Medium Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030

        11.2.1. Swab Type

            11.2.1.1. Nasal Swabs

            11.2.1.2. Nasopharyngeal Swabs

            11.2.1.3. Throat Swabs 

        11.2.2. Transport Medium 

    11.3. Europe Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030

        11.3.1. Viral Infection Diagnosis

            11.3.1.1. COVID-19

            11.3.1.2. Influenza

            11.3.1.3. Herpes Simplex Virus

            11.3.1.4. Varicella-zoster Virus

            11.3.1.5. Others

        11.3.2. Others 

    11.4. Europe Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030

        11.4.1. Hospitals & Clinics

        11.4.2. Microbiology Laboratories

        11.4.3. Diagnostic Laboratories

        11.4.4. Others  

    11.5. Europe Swab and Viral Transport Medium Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Swab and Viral Transport Medium Market Attractiveness Analysis 

        11.6.1. By Product 

        11.6.2. By Application

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Asia Pacific Swab and Viral Transport Medium Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030

        12.2.1. Swab Type

            12.2.1.1. Nasal Swabs

            12.2.1.2. Nasopharyngeal Swabs

            12.2.1.3. Throat Swabs 

        12.2.2. Transport Medium 

    12.3. Asia Pacific Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030

        12.3.1. Viral Infection Diagnosis

            12.3.1.1. COVID-19

            12.3.1.2. Influenza

            12.3.1.3. Herpes Simplex Virus

            12.3.1.4. Varicella-zoster Virus

            12.3.1.5. Others

        12.3.2. Others 

    12.4. Asia Pacific Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030

        12.4.1. Hospitals & Clinics

        12.4.2. Microbiology Laboratories

        12.4.3. Diagnostic Laboratories

        12.4.4. Others  

    12.5. Asia Pacific Swab and Viral Transport Medium Market Value Forecast, by Country/Sub-region, 2018–2030

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis 

        12.6.1. By Product 

        12.6.2. By Application

        12.6.3. By End-user 

        12.6.4. By Country/Sub-region

13. Latin America Swab and Viral Transport Medium Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030

        13.2.1. Swab Type

            13.2.1.1. Nasal Swabs

            13.2.1.2. Nasopharyngeal Swabs

            13.2.1.3. Throat Swabs 

        13.2.2. Transport Medium 

    13.3. Latin America Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030

        13.3.1. Viral Infection Diagnosis

            13.3.1.1. COVID-19

            13.3.1.2. Influenza

            13.3.1.3. Herpes Simplex Virus

            13.3.1.4. Varicella-zoster Virus

            13.3.1.5. Others

    13.4. Others 

    13.5. Latin America Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030

        13.5.1. Hospitals & Clinics

        13.5.2. Microbiology Laboratories

        13.5.3. Diagnostic Laboratories

        13.5.4. Others  

    13.6. Latin America Swab and Viral Transport Medium Market Value Forecast, by Country/Sub-region, 2018–2030

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Latin America Swab and Viral Transport Medium Market Attractiveness Analysis 

        13.7.1. By Product 

        13.7.2. By Application

        13.7.3. By End-user 

        13.7.4. By Country/Sub-region

14. Middle East & Africa Swab and Viral Transport Medium Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030

        14.2.1. Swab Type

            14.2.1.1. Nasal Swabs

            14.2.1.2. Nasopharyngeal Swabs

            14.2.1.3. Throat Swabs 

        14.2.2. Transport Medium 

    14.3. Middle East & Africa Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030

        14.3.1. Viral Infection Diagnosis

            14.3.1.1. COVID-19

            14.3.1.2. Influenza

            14.3.1.3. Herpes Simplex Virus

            14.3.1.4. Varicella-zoster Virus

            14.3.1.5. Others

        14.3.2. Others 

    14.4. Middle East & Africa Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030

        14.4.1. Hospitals & Clinics

        14.4.2. Microbiology Laboratories

        14.4.3. Diagnostic Laboratories

        14.4.4. Others  

    14.5. Middle East & Africa Swab and Viral Transport Medium Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis 

        14.6.1. By Product 

        14.6.2. By Application

        14.6.3. By End-user 

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2019

    15.3. Company Profiles

        15.3.1. Thermo Fisher Scientific 

            15.3.1.1. Company Overview

            15.3.1.2. Company Financials

            15.3.1.3. Growth Strategies

            15.3.1.4. SWOT Analysis

        15.3.2. Becton, Dickinson and Company (BD)

            15.3.2.1. Company Overview

            15.3.2.2. Company Financials

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis

        15.3.3. MWE

            15.3.3.1. Company Overview

            15.3.3.2. Company Financials

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis

        15.3.4. Titan Biotech Ltd.

            15.3.4.1. Company Overview

            15.3.4.2. Company Financials

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5. COPAN Diagnostics, Inc.

            15.3.5.1. Company Overview

            15.3.5.2. Company Financials

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis

        15.3.6. MANTACC 

            15.3.6.1. Company Overview

            15.3.6.2. Company Financials

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis

        15.3.7. Puritan Medical Products 

            15.3.7.1.  Company Overview

            15.3.7.2. Company Financials

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis

        15.3.8. YOCON Biology

            15.3.8.1. Company Overview

            15.3.8.2. Company Financials

            15.3.8.3. Growth Strategies

            15.3.8.4. SWOT Analysis

        15.3.9. Trinity Biotech 

            15.3.9.1. Company Overview

            15.3.9.2. Company Financials

            15.3.9.3. Growth Strategies

            15.3.9.4. SWOT Analysis

        15.3.10. VIRCELL S.L.

            15.3.10.1. Company Overview

            15.3.10.2. Company Financials

            15.3.10.3. Growth Strategies

            15.3.10.4. SWOT Analysis

        15.3.11. Other Prominent Key Players

List of Tables

Table: 1 Global Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030

Table: 2 Global Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030

Table: 3 Global Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by End-user, 2018–2030

Table: 4 Global Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table: 5 North America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030

Table: 6 North America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030

Table: 7 North America Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table: 8 North America Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table: 9 Europe Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030

Table: 10 Europe Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030

Table: 11 Europe Swab and Viral Transport Medium Market Revenue (US$ Mn) Forecast, by End-user, 2018–2030

Table: 12 Europe Swab and Viral Transport Medium Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table: 13 Asia Pacific Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030

Table: 14 Asia Pacific Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030

Table: 15 Asia Pacific Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table: 16 Asia Pacific Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table: 17 Latin America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030

Table: 18 Latin America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030

Table: 19 Latin America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by End-user, 2018–2030

Table: 20 Latin America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table: 21 Middle East & Africa Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030

Table: 22 Middle East & Africa Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030

Table: 23 Middle East & Africa Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table: 24 Middle East & Africa Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

List of Figures

Figure: 1 Global Swab and Viral Transport Medium Market Value, by Product (US$ Mn), 2019

Figure: 2 Global Swab and Viral Transport Medium Market Share Top Trends, by Product, 2019

Figure: 3 Global Swab and Viral Transport Medium Market Share, by Region, 2019

Figure: 4 Global Swab and Viral Transport Medium Market Share Analysis, by Region

Figure: 5 Global Swab and Viral Transport Medium Market - Porter’s Five Forces Analysis

Figure: 6 Global Swab and Viral Transport Medium Market Value (US$ Mn) and Forecast, 2020–2028

Figure: 7 Global Swab and Viral Transport Medium Market Value Share Analysis, by Region, 2019 and 2030

Figure: 8 Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Region, 2020–2028

Figure: 9 Global Swab and Viral Transport Medium Market Value Share, by Product 2019 and 2030

Figure: 10 Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2020–2028

Figure: 11 Global Swab and Viral Transport Medium Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Swab Type, 2018–2030

Figure: 12 Global Swab and Viral Transport Medium Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Transport Medium, 2018–2030

Figure: 13 Global Swab and Viral Transport Medium Market Value Share, by Application 2019 and 2030

Figure: 14 Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2020–2028

Figure: 15 Global Swab and Viral Transport Medium Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Viral Infection Diagnosis, 2018–2030

Figure: 16 Global Swab and Viral Transport Medium Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2030

Figure: 17 Global Swab and Viral Transport Medium Market Value Share, by End user 2019 and 2030

Figure: 18 Global Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2020–2028

Figure: 19 North America Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030

Figure: 20 North America Swab and Viral Transport Medium Market Value Share Analysis, by Country, 2019 and 2030

Figure: 21 North America Swab and Viral Transport Medium Market Attractiveness Analysis, by Country, 2020–2028

Figure: 22 North America Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030

Figure: 23 North America Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027

Figure: 24 North America Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030

Figure: 25 North America Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027

Figure: 26 North America Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030

Figure: 27 North America Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027

Figure: 28 Europe Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030

Figure: 29 Europe Swab and Viral Transport Medium Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure: 30 Europe Swab and Viral Transport Medium Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

Figure: 31 Europe Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030

Figure: 32 Europe Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027

Figure: 33 Europe Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030

Figure: 34 Europe Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027

Figure: 35 Europe Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030

Figure: 36 Europe Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027

Figure: 37 Asia Pacific Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030

Figure: 38 Asia Pacific Swab and Viral Transport Medium Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure: 39 Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

Figure: 40 Asia Pacific Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030

Figure: 41 Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027

Figure: 42 Asia Pacific Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030

Figure: 43 Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027

Figure: 44 Asia Pacific Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030

Figure: 45 Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027

Figure: 46 Latin America Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030

Figure: 47 Latin America Swab and Viral Transport Medium Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure: 48 Latin America Swab and Viral Transport Medium Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

Figure: 49 Latin America Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030

Figure: 50 Latin America Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027

Figure: 51 Latin America Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030

Figure: 52 Latin America Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027

Figure: 53 Latin America Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030

Figure: 54 Latin America Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027

Figure: 55 Middle East & Africa Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030

Figure: 56 Middle East & Africa Swab and Viral Transport Medium Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure: 57 Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

Figure: 58 Middle East & Africa Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030

Figure: 59 Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027

Figure: 60 Middle East & Africa Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030

Figure: 61 Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027

Figure: 62 Middle East & Africa Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030

Figure: 63 Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027

Figure: 64 Thermo Fisher Scientific Revenue (US$ Bn) and Y-o-Y Growth (%), 2019

Figure: 65 Thermo Fisher Scientific Research & Development Expenses, 2019

Figure: 66 Thermo Fisher Scientific Breakdown of Net Sales (% Share), by Business Segment, 2019

Figure: 67 Thermo Fisher Scientific Breakdown of Net Sales (% Share), by Region, 2019

Figure: 68 C. R. Bard, Inc. (Becton, Dickinson and Company) Revenue (US$ Bn) and Y-o-Y Growth (%), 2019

Figure: 69 C. R. Bard, Inc. (Becton, Dickinson and Company) Research & Development Expenses, 2019

Figure: 70 C. R. Bard, Inc. (Becton, Dickinson and Company) Breakdown of Net Sales (% Share), by Business Segment, 2019

Figure: 71 C. R. Bard, Inc. (Becton, Dickinson and Company) Breakdown of Net Sales (% Share), by Region (2019)

Figure: 72 Titan Biotech Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure: 73 Trinity Biotech Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019

Figure: 74 Trinity Biotech Research and development expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure: 75 Trinity Biotech Breakdown of Net Sales (%), by Region, 2019

Figure: 76 Trinity Biotech Breakdown of Net Sales (%), by Business Segment, 2019

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Swab And Viral Transport Medium Market